Anti-ARID1A/BAF250 Antibody (Clone 3A12)

<strong>anti-ARID1A/BAF250 Antibody (Clone 3A12)</strong>_x000D_ <strong>Catalog number:</strong> B2015208_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 50 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> 2 - 8 °C_x000D_ <strong>Keywords:</strong> ARID domain-containing protein 1A;AT rich interactive domain 1A (SWI-like);AT-rich interactive domain-containing protein 1A;B120;BAF250;BAF250a;BM029;brain protein 120;BRG1-associated factor 250;BRG1-associated factor 250a_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Faraj SF, Chaux A, Gonzalez-Roibon N, Munari E, Cubilla AL, Shih IeM, Netto GJ. Immunohistochemical expression of ARID1A in penile squamous cell carcinomas: a tissue microarray study of 112 cases Hum Pathol. 2015 May;46(5):761-6._x000D_ 2: Inoue H, Giannakopoulos S, Parkhurst CN, Matsumura T, Kono EA, Furukawa T, Tanese N. Target genes of the largest human SWI/SNF complex subunit control cell growth Biochem J. 2011 Feb 15;434(1):83-92._x000D_ 3: Pranckėnienė L, Siavrienė E, Gueneau L, Preikšaitienė E, Mikštienė V, Reymond A, Kučinskas V. De novo splice site variant of ARID1B associated with pathogenesis of Coffin-Siris syndrome Mol Genet Genomic Med. 2019 Dec;7(12):e1006._x000D_ 4: Shibata Y, Uchida M, Takeshita H, Nishiwaki K, Sawa H. Multiple functions of PBRM-1/Polybromo- and LET-526/Osa-containing chromatin remodeling complexes in C. elegans development Dev Biol. 2012 Jan 15;361(2):349-57._x000D_ 5: Hsiao PW, Fryer CJ, Trotter KW, Wang W, Archer TK. BAF60a mediates critical interactions between nuclear receptors and the BRG1 chromatin-remodeling complex for transactivation Mol Cell Biol. 2003 Sep;23(17):6210-20._x000D_ 6: Decristofaro MF, Betz BL, Rorie CJ, Reisman DN, Wang W, Weissman BE. Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies J Cell Physiol. 2001 Jan;186(1):136-45._x000D_ 7: Han Y, Reyes AA, Malik S, He Y. Cryo-EM structure of SWI/SNF complex bound to a nucleosome Nature. 2020 Mar;579(7799):452-455._x000D_ 8: Zhang ZM, Xiao S, Sun GY, Liu YP, Zhang FH, Yang HF, Li J, Qiu HB, Liu Y, Zhang C, Kang S, Shan BE. The clinicopathologic significance of the loss of BAF250a (ARID1A) expression in endometrial carcinoma Int J Gynecol Cancer. 2014 Mar;24(3):534-40._x000D_ 9: Maeda D, Mao TL, Fukayama M, Nakagawa S, Yano T, Taketani Y, Shih IeM. Clinicopathological significance of loss of ARID1A immunoreactivity in ovarian clear cell carcinoma Int J Mol Sci. 2010;11(12):5120-8._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/26278180">10: Muratcioglu S, Presman DM, Pooley JR, Grøntved L, Hager GL, Nussinov R, Keskin O, Gursoy A. Structural Modeling of GR Interactions with the SWI/SNF Chromatin Remodeling Complex and C/EBP Biophys J. 2015 Sep 15;109(6):1227-39. </a>_x000D_ _x000D_ <strong>Products Related to anti-ARID1A/BAF250 Antibody (Clone 3A12) can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>